DUMONT & BLAKE INVESTMENT ADVISORS LLC - AGILE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
DUMONT & BLAKE INVESTMENT ADVISORS LLC ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$67,000
-54.1%
70,000
-36.4%
0.02%
-54.8%
Q2 2021$146,000
-29.8%
110,000
+10.0%
0.04%
-34.4%
Q1 2021$208,000
-27.5%
100,0000.0%0.06%
-34.7%
Q4 2020$287,000
-5.6%
100,0000.0%0.10%
-14.8%
Q3 2020$304,000
+27.2%
100,000
+16.3%
0.12%
+15.0%
Q2 2020$239,000
+111.5%
86,000
+41.0%
0.10%
+72.4%
Q1 2020$113,00061,0000.06%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 15,919,925$15,301,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$706,0000.09%
INVESTOR AB 3,510,189$3,370,0000.09%
GSA CAPITAL PARTNERS LLP 586,491$564,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 335,735$322,0000.05%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 70,000$67,0000.02%
Summit Global Investments 126,000$121,0000.01%
Ergoteles LLC 211,611$203,0000.01%
Centric Wealth Management 10,000$10,0000.00%
GRIMES & COMPANY, INC. 99,744$96,0000.00%
View complete list of AGILE THERAPEUTICS INC shareholders